Nortis Nortis, an Seattle-based startup established in 2011, which markets “organ-on-a-chip” technology, has received $6 million in funding, as per the SEC report.
The company’s microfluidic chip promotes the development of cells from humans in ways which mimic organs. They’ve been utilized to develop kidney liver, liver, blood vessel and intestine, heart as well as tumor model models to scientists.
Nortis has been granted support through The Bill & Melinda Gates Foundation and worked with the foundation on a plan to send the kidney chip to space. Its chips are utilized for research. The company was spun off from VisionGate which is run by Thomas Neumann, an ex-executive at VisionGate.
We’ve called the company for more information about the new funding , and will update you if we receive a response.